VAVinicyus Eduardo Melo Amorim

Vinicyus Eduardo Melo Amorim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vinicyus Eduardo Melo Amorim has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of the OSCE in assessing performance in first aid of high school students

    by Vinicyus Eduardo Melo Amorim, Renan Gatis Ayres, Mikhael Morais de Souza, Ana Cecília Araújo Cabral, Bruna Sampaio Tavares, Tiago Fernando Ferreira da Silva, Felipe César Gomes de Andrade, Luciano Calheiros de Morais Guerra, Edvaldo da Silva Souza

    Highlights ■ Training markedly improves theoretical knowledge and performance in cardiopulmonary resuscitation and foreign body airway obstruction management. ■ Significant knowledge and skills, particularly in the Heimlich maneuver, remain after 6 months. ■ The objective structured clinical examination is a practical and reliable method to evaluate first-aid skills in schools. ABSTRACT Objective: To assess the knowledge and performance of high school students in cardiopulmonary resuscitation and foreign body airway obstruction management using an objective structured clinical examination. Methods: An interventional

  • Open Access

    Lipectomia e lipoaspiração seriadas para manejo de síndrome de Madelung: A respeito de um caso

    by Pedro Henrique DE Araújo Silva, Jairo Zacchê DE Sá, Flávio José Teixeira Rocha Ataíde DA Motta, Helena Gabriele Alves Castro, Vinicyus Eduardo Melo Amorim, Andresa DOS Santos Viana, Larissa Carareto Bravin, Pedro Henrique Pontual

    ▪ RESUMO: A doença de Madelung é caracterizada pelo acúmulo simétrico e difuso de tecido adiposo com crescimento tumoral lento e progressivo. Neste relato de caso, um paciente portador dessa síndrome foi atendido no Hospital das Clínicas, em Recife, PE, com o objetivo de realizar uma redução do conteúdo lipomatoso através de lipectomia. O paciente apresentava volumosas massas de tecido adiposo elástico ao redor do pescoço e região supraclavicular e a proposta terapêutica consistiu em uma cirurgia em dois tempos, com lipoaspiração e lipectomia cervical anterior, seguida de lipoaspiração e lipectomia cervical posterior. Antes da cirurgia, foi solicitado um parecer cardiológico, que indicou um risco intermediário, mas não contraindicou o procedimento. Após 4 dias da cirurgia, o paciente apresentou equimoses e edema periférico na ferida operatória cervical, porém estava assintomático. As técnicas de lipectomia e lipoaspiração são consideradas os métodos de tratamento mais eficazes para a doença de Madelung. No entanto, a escolha da cirurgia deve ser baseada em uma avaliação abrangente da gravidade da doença, localização da massa e expectativas do paciente, uma vez que ambas as técnicas possuem vantagens e desvantagens.

  • Open Access

    Preoperative hypovitaminosis D and complications in plastic surgery: a pilot study

    by Flávio José Teixeira Rocha Ataíde DA Motta, Igor Chaves Gomes Luna, Isadora Moscardini Fabiani, Júlia Cibely DA Silva Souza, Vinicyus Eduardo Melo Amorim, Jairo Zacchê DE Sá

    Introduction: Vitamin D plays a crucial role in various biological processes, including the well-known regulation of the immune system and calcium metabolism. While its involvement in the surgical outcomes of various medical specialties is recognized, there is a lack of consistent data regarding plastic surgery. This study aimed to assess preoperative serum levels of 25-hydroxyvitamin D and its relationship with complications in patients undergoing reconstructive and aesthetic plastic surgeries. Methods: prospective and observational cohort study, conducted from October 2021 to August 2023 at the Hospital das Clínicas, Universidade Federal de Pernambuco, involving 83 patients. Results: vitamin D levels were deemed deficient in 7 (8,4%) patients, insufficient in 36 (43,4%), and sufficient in 40 (48,2%). No direct association was demonstrated between deficient or insufficient serum levels of 25-hydroxyvitamin D and the incidence of complications in plastic surgery, even when considering comorbidities. Conclusion: preoperative hypovitaminosis D was not associated with complications in plastic surgery.

  • Open Access

    Hipovitaminose D pré-operatória e complicações em cirurgia plástica: estudo piloto

    by Flávio José Teixeira Rocha Ataíde DA Motta, Igor Chaves Gomes Luna, Isadora Moscardini Fabiani, Júlia Cibely DA Silva Souza, Vinicyus Eduardo Melo Amorim, Jairo Zacchê DE Sá

    RESUMO Introdução: a vitamina D é parte constituinte de diversos processos biológicos. Além da conhecida regulação do sistema imunológico e do metabolismo do cálcio, está envolvida no desfecho cirúrgico de diversas especialidades, porém não há dados consistentes sobre cirurgia plástica. Este estudo teve como objetivo avaliar os níveis séricos pré-operatórios de 25-hidroxivitamina D e sua relação com complicações em pacientes submetidos a cirurgias plásticas reparadoras e estéticas. Métodos: coorte prospectiva e observacional, conduzida de outubro de 2021 a agosto de 2023 no Hospital das Clínicas da Universidade Federal de Pernambuco, em 83 pacientes. Resultados: os níveis de vitamina D foram considerados deficientes em 7 (8,4%) dos pacientes, insuficientes em 36 (43,4%) e suficientes em 40 (48,2%). Não se demonstrou associação direta entre níveis séricos deficientes ou insuficientes de 25-hidroxivitamina D e a incidência de complicações em cirurgia plástica, nem mesmo quando associado a comorbidades Conclusão: a hipovitaminose D pré-operatória não foi associada a complicações em cirurgia plástica.

  • Open Access

    APPLICABILITY OF PROBIOTICS IN DIARRHEAL SYNDROMES: WHAT DOES THE EVIDENCE SAY?

    by Vinicyus Eduardo Melo Amorim, Mariana Cantarelli Freire, Enzo Lima Maia Leite, Felipe Santos da Silva, Vitor Oitaven Andrade de Amorim, Isadora Nascimento de Carvalho, Italo Matheus Da Silva Pequeno, José Gilberto de Oliveira Júnior, Janaína Albuquerque Santos, Thalita Marcelle Lisboa da Trindade, et al.

    Probiotics are live microorganisms beneficial to health, which can be used as food supplements or added to foods such as yogurt and fermented milk. Probiotics are classified into different types, such as Lactobacillus and Bifidobacterium species, and act in different ways, such as colonizing the gastrointestinal tract, modulating the intestinal microbiota and stimulating the immune system. Probiotics have been widely studied in relation to their use in the treatment of several syndromes, such as acute and chronic diarrhea, irritable bowel syndrome, celiac disease, Crohn's disease and ulcerative colitis. In acute diarrhea, probiotics have been shown to be effective in reducing the duration of diarrhea and decreasing the number of bowel movements. In chronic diarrhea, probiotics have also shown positive effects in reducing symptoms and improving patients' quality of life. In irritable bowel syndrome, probiotics have been studied as a promising alternative to conventional treatment, due to their ability to modulate the intestinal microbiota and reduce inflammation. In celiac disease, probiotics have been investigated as a possible way to improve gluten tolerance and reduce intestinal inflammation. In Crohn's disease and ulcerative colitis, probiotics have been studied as a way to reduce intestinal inflammation and improve the body's immune response. Thus, studies show that the use of probiotics is safe and can bring significant benefits to patients with different syndromes. However, it is important to highlight that the use of probiotics must be done under medical guidance and that more research is needed to better understand the action of probiotics and identify the best strains for each type of syndrome.

  • Open Access

    ANALYSIS OF THE DEVELOPMENT OF MYCOTIC INFECTIONS IN PATIENTS USING CANAGLIFLOZIN AND DAPAGLIFLOZIN: A NARRATIVE REVIEW

    by Vinicyus Eduardo Melo Amorim, Heloise Gabriella Queiroz Moura, Camilla Maria Galvão Gomes, Emilley Andrade Cunha, Kethly de Andrade Cunha, Felipe Oliveira Miranda de Melo, Maria Beatriz Nunes de Figueiredo Medeiros, Enderson Lima Pedrosa de Melo, Renata Correia Carvalho Novaes Ferraz Maia, Felipe Santos da Silva, et al.

    SGLT-2 inhibitors are very useful and effective medications for treating hyperglycemia and reducing cardiovascular risk. However, it is responsible for increasing the IGM index, especially in women, three to four times when compared to a placebo group. As such, it is imperative that healthcare professionals are aware of the benefits, risks, and strategies for increasing safety and efficacy, and managing SGLT2 inhibitor-related issues. The incidence, risk factors, prevention and management of IGMs associated with SGLT2 inhibitors must be discussed as part of shared decision-making models. Furthermore, risk mitigation must include optimizing glycemic, metabolic, and cardiovascular management strategies, as well as providing personal hygiene advice, avoiding unnecessary discontinuation of therapy with SGLT2 inhibitors.